PolyNovo Showcases NovoSorb® Technology at the American Burn Association 2026 Annual Meeting

Melbourne, Australia – 13 April 2026

PolyNovo Limited (ASX: PNV), a leading medical technology company transforming the management of complex wounds, today announces its upcoming participation in the American Burn Association (ABA) Annual Meeting 2026, to be held in Orlando, Florida from 14–17 April 2026.

The ABA 2026 Annual Meeting is an established forum for burn care professionals, bringing together more than 2,000 surgeons, clinicians, and researchers from across the United States and around the globe, focused on advancements in the treatment of burn injuries and complex wounds.

PolyNovo will have an exhibition presence at Booth #501, where the Company will engage with clinicians on recent advancements in the clinical application of the NovoSorb® technology platform.

Attendees visiting the PolyNovo booth can expect hands-on demonstrations of NovoSorb® technology, real-world case study discussions, and one-on-one engagement with clinical and commercial team members.

As part of its presence at ABA 2026, PolyNovo will host and participate in several key activities throughout the meeting, including:

• Welcome Reception - Tuesday, 14 April, 5:00–7:00 PM (Exhibit Hall)

• In-Booth Clinical Demonstrations featuring Caroline Joseph, PA-C, and Dana Nakamura, OTR/L, CLT, CLMC - Wednesday, 15 April, 12:15–1:15 PM

• Innovation Theatre Presentation and Meet & Greet: The NovoSorb® Platform: Where NovoSorb® MTX Fits presented by Jonathan Schoen, MD, MPH, FACS, FABA - Thursday, 16 April, 12:00–1:00 PM

• ABA Passport to Prizes Program - Taking place throughout the week at Booth #501

Members of the Company’s executive leadership team, including Bruce Peatey (Chief Executive Officer), Ed Graubart (President, North America), and Joshua Cheetham (Vice President, Research & Development, Australia), will attend the meeting to connect with customers, partners, and stakeholders.

PolyNovo’s presence at ABA 2026 underscores its continued commitment to advancing clinical outcomes in burn care through innovative, synthetic solutions and collaborative engagement with the global burn community.

Media contact: [email protected]